MetaCap

Braveheart Bio (BRVE) vs Schrodinger (SDGR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Schrodinger is the larger company by market cap ($1.72 billion vs $1.67 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BRVE-31.58%SDGR+28.75%
+94%+23%-48%
Aug 6, 20261 yearNov 20, 2026
BRVE-32.03%SDGR+26.27%
+72%+14%-43%
Aug 3, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BRVE versus SDGR key metrics
MetricBRVESDGR
Share price$20.39$22.93
Market cap$1.67B$1.72B
1-day change+5.81%-12.95%
YTD return—+28.24%
1-year return—+39.22%
5-year return—-42.01%
EPS (TTM)$-6.59$-0.79
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$255.87M
Revenue growth (YoY)—+23.29%
Net income (latest FY)—$-103.27M
Gross margin—55.74%
Operating margin—-65.23%
Net margin—-40.36%
52-week high$32.00$34.00
52-week low$16.70$10.95
Distance from 52-week high-36.28%-32.56%
Analyst consensusstrong_buybuy
Avg. price target upside+123.15%+46.40%
Average volume491.27K2.08M
Shares outstanding82.07M65.91M
Employees49850
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Braveheart Bio

BRVE stock →

Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 49 employees

About Schrodinger

SDGR stock →

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery.

Health Care · Biotechnology: Pharmaceutical Preparations · 850 employees

BRVE vs SDGR FAQ

Which is bigger, Braveheart Bio or Schrodinger?

Schrodinger (SDGR) is larger, with a market capitalization of $1.72B compared with $1.67B for Braveheart Bio (BRVE).

Are Braveheart Bio and Schrodinger in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons